To test the anti-fibrogenic effects of CM414, we took advantage of Mdr2-KO mice, which as mentioned above, is a clinically relevant model of spontaneous CLD, fibrosis, and HCC/CCA development. The gene discussed is ABCB4; the disease is congenital secretory chloride diarrhea 1.